Crossmark

RETRACTED ARTICLE: Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer’s Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway

Crossref DOI link: https://doi.org/10.1007/s12640-022-00482-x

Published Online: 2022-02-22

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hasan, Noorul

Zameer, Saima

Najmi, Abul Kalam

Parvez, Suhel

Akhtar, Mohd https://orcid.org/0000-0002-3333-2672
License Information

Text and Data Mining valid from 2022-02-22

Version of Record valid from 2022-02-22
More Information

Article History

Received: 4 October 2021

Revised: 20 January 2022

Accepted: 14 February 2022

First Online: 22 February 2022

Change Date: 15 July 2024

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1007/s12640-024-00713-3

Declarations

:

: All of the tests were carried out in accordance with the rules established by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). The experimental procedure was approved by Jamia Hamdard Institutional Animal Ethics Committee (IAEC) under protocol number 1815.

: The authors declare no competing interests.

Retraction Retraction dated 2024-07-15

Click to view Retraction: https://doi.org/10.1007/s12640-024-00713-3